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ABSTRACT 
Objective: This study was aimed to compare the preservative efficacy of thimerosal in eye drops formulation containing neomycin sulfate and 
chloramphenicol as the active agents. 
Methods: Determination of thimerosal concentration in combinations with chloramphenicol and neomycin sulfate was carried out using the agar 
diffusion method. Then the thimerosal ineffective and minimal concentration was formulated into eye drops, each with 0.5% neomycin sulfate and 
0.5% chloramphenicol as the active ingredient. Evaluation of eye drops was carried out for 28 d, which included: visual observation, pH 
measurement, sterility, and effectiveness test. 
Results: Thimerosal at a minimum concentration of 0.001% remain to provide antibacterial activity against common eyes contaminants. Both eyes 
drops containing neomycin sulfate, and chloramphenicol resulted in clear solution, sterile, and stable in the pH and antibacterial potency,showed 
the efficacy of thimerosal’s role in eye drops at the lowest concentration. But, the thimerosal stability as a preservative agent was affected by the pH 
values of the eye drops solution. Therefore, the effectivity of thimerosal in chloramphenicol (pH 7.19-7.22) was better than neomycin sulfate (6.45-
6.60). Compared with F0 (without thimerosal), the increasing of inhibitory diameter in F1 and F2 from both eyes drops formula exhibited the 
significant role of thimerosal as the preservative agent. The synergistic effect of the preservative agent in the formula produced a better product 
stability than the eye drop without thimerosal.  
Conclusion: Thimerosal at a minimum concentration of 0.001% exhibited effective concentration as a preservative in eye drops containing 0.5% 
neomycin sulfate and 0.5% chloramphenicol.  
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INTRODUCTION 
The eyes are parts or tools of the body that are highly sensitive to 
external influences. The, therefore, the eye needs treatment to function 
properly and does not experience infection. Eye infections occur when 
pathogenic microorganisms in the form of viruses, bacteria, fungi, or 
parasites multiply in the eye. The eye infections are majority 
contributed from exogenous contaminants and also related to 
microbial air pollution from indoor environment and seasonality [1-3]. 
The airborne contaminants that spread through the hands can be an 
alternative source of eye infection that is meaningful [4]. Moreover, 
the eye contaminant may come from the used of ophthalmic solutions. 
The eye infections caused by contaminants from air pollution, 
contaminated ophthalmic medications or other reasons, lead damage 
to the functional structures of the eyes and may cause blindness [5-7]. 
Others eyes infections such as endophthalmitis and bacterial keratitis 
were reported to be correlated with the use of contaminated topical 
eye medications [8, 9]. The bacterial contaminants in ophthalmic 
solutions may alter the pH preparation and lead to reducing the 
medical efficacy of the treatment [10]. 
The ophthalmic product solutions have been reported to be 
contaminated with pathogens and caused ocular infections [11]. 
Several studies reported that bacterial contamination rates in 
ophthalmic solution bottles were in ranged of 2.3-70% with 
commonly isolated bacteria such as: Pseudomonas, Staphylococcus 
aureus, coagulase-negative Staphylococcus, Bacillus, Enterobacter, 
Proteus, Klebsiella spp and Serratia [12-15]. These reports were 
supported by other research that examined 
The main function of preservatives is to decrease the risk of 
infection by preventing the growth of microorganisms which can 
cause degradation of the drug; thus, the product sterility is assured 
and maintained during use. In eye care, besides preservative has to 
kill microbes, but several preservatives can cause a little bit of 
toxicity to the ocular surface. Thimerosal is one of common 
preservative, used in eye drops preparation. But in vaccine 
preparation, because of its organic-mercury (Hg) based compound in 
thimerosal, it was reported to be harmful. In contrast, the United 
States Centers for Disease Control and Prevention states that 
Thimerosal is safe and there is no relationship between thimerosal-
containing vaccines and autism rates in children [18]. Therefore, 
considering the efficacy of thimerosal as preservatives in eye drops 
preparation, this study concerned with the determination of the low 
concentration of thimerosal that remains effectively in preventing the 
contaminant growth. 
92 eye drop bottles: 43 
bottles were opened and used, and 49 bottles were sealed. The 
results showed that the contamination rates were higher obtain 
from the opened bottle than unopened bottles. The coagulase-
negative Staphylococci, S. aureus, and Bacillus, were found as 
contaminants from both eye drop bottle treatment [16]. Another 
study also reported that the contamination sources in eye drop 
product were mostly from the caps (45.9%), from droppers (41.0%) 
and residual contents (13.1%) [17]. Therefore, most ophthalmic 
preparations always use preservatives to inhibit the growth of 
microbial contamination.  
In this study, the efficacy of thimerosal as a preservative was tested 
on two eye drop formulas, each containing neomycin sulfate, and 
chloramphenicol antibiotics. Neomycin is a commonly useful 
antibiotic for ocular use and has broad spectrum against Gram-
positive and Gram-negative bacteria. In addition, than polymyxin B, 
neomycin is more effective against Proteus vulgaris [19]. Neomycin 
sulfate eye drops in repeated use (multi doses) which do not contain 
preservatives are reported to be ineffective. However, the use of 
chloramphenicol as an antibiotic in an ophthalmic preparation is the 
gold standard and being prescribed in 55% of red eyes [20, 21]. The 
efficacy of chloramphenicol has achieved of 91% to 93% in ocular 
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infections [22, 23] and effectively inhibit up to 94% eye pathogens 
[20]. The efficacy of chloramphenicol was supported because of its 
high differential solubility resulting in high intraocular penetration. 
Chloramphenicol also has a superior effect to most other antibiotics 
for prophylaxis in ocular surgery [21, 24]. 
MATERIALS AND METHODS 
Materials 
The microbes used in this study were Staphylococcus aureus, S. 
epidermidis, Pseudomonas aeruginosa, Bacillus subtillis and Candida 
albicans were obtained from the Microbiology Laboratory, Faculty of 
Pharmacy, Padjajaran University and Pathology Laboratory of Hasan 
Sadikin Hospital Bandung. Indonesia. The kinds of microbial growth 
medium used were Mueller Hinton Agar/MHA (Oxoid), Mueller 
Hinton Broth/MHB (Oxoid), Fluid Thioglicolate Medium/FTM 
(Oxoid), and Soybean Casein/SC (Pronadisa). The chemicals used 
were the antibiotic neomycin sulfate (PT. Cendo 
Indonesia),disodium hydrogen phosphate (Merck), disodium 
phosphate (PT. Brataco Indonesia), sodium chloride(Merck), 
disodium edetate (J. T. Baker), sodium metabisulfite (PT. Brataco 
Indonesia), thimerosal (PT. Cendo Indonesia), sodium tetraborate 
(Merck), boric acid (Merck) and redistillata water (PT. 
Ikapharmindo Indonesia). 
Preparation of microbial suspension 
One Ose of each bacterial colony was suspended in MHB and 
incubated at 370C for 18 h. The final bacterial inoculum 
concentration was adjusted to0.5 Mc Farland (1.5x108 (cfu/ml) [25]. 
McFarland solution consisted of two components, 1% BaCl2 and 1% 
H2SO4. A total of 0.05 ml of 1% BaCl2 solution was mixed with 9.95 
ml of 1% H2SO4
Determination of thimerosal concentration 
 solution and shaken homogeneously. The turbidity 
of the solution was measured at a wavelength of 530 nm by using 
distilled water as a blank [26]. 
Determination of the minimum concentration of thimerosal in two 
eye drop formulas which each contained 0.5% neomycin sulfate 
antibiotics and 0.5% chloramphenicol were carried out using the 
agar diffusion method. The variation of thimerosal concentration 
used to be as follows: 0.02%;0,015%; 0.01%; 0.005% and 0.001%. A 
total of 20 µl bacterial suspension was poured intoa sterile petri dish 
containing MHA (45 °C), then the bacterial suspension was 
homogenized and allowed to solidify at room temperature. The 
media were then perforated using perforator aseptically. Each hole 
was filled with 50 µl of each formula solution and incubated for 18 h 
at 37 °C. The combined antibacterial activity was compared with the 
antibacterial activity of neomycin sulfate/chloramphenicol and 
thimerosal in a single state. The inhibitory diameters were 
measured using a caliper [27]. 
Eye drops formulation 
The eye drop formulation consisted of a positive control formula 
(F1) with a 0.01% preservative concentration, a tested formula (F2) 
with a concentration of 0.001% thimerosal, and a negative control 
formula (F0) made without using thimerosal.  
The aim of this design experiment procedure was to evaluate the 
efficacy of eye drops with thimerosal preservatives at 0.001% 
against negative controls and to determine the effect of differences 
in thimerosal concentration compared with positive controls. Eye 
drops preparation formulations can be seen in table 1 and 2. 
 
Table 1: 0.5% neomycin sulfate eye drop formula 
Composition F0 (%) F1 (%) F2 (%) 
Neomycin sulfate 0.50 0.50 0.50 
Sodium Dihydrogen Phosphate 0.70 0.70 0.70 
Disodium phosphate 0.70 0.70 0.70 
Sodium chloride 0.40 0.40 0.40 
Disodium edetate 0.10 0.10 0.10 
Thimerosal 0.00 0.01 0.001 
Sodium metabisulfite 0.20 0.20 0.20 
Sterile aqua pro injection (API) Ad 100 Ad 100 Ad 100 
 
The formulation process of mixing ingredients for 0.5% 
neomycin sulfate eye drops were carried out in the Laminar Air 
Flow (LAF) room. Neomycin sulfate, disodium Hydrogen 
Phosphate, sodium chloride, disodium edetate, and disodium 
Phosphate were dissolved in a part of the sterile aqua pro 
injection (API). After that, the thimerosal solution was added. 
After all, components were mixed, the API was added, and then 
the pH solution was measured. The solution was then sterilized 
using a bacterial filter. After that, the sterilized preparations 
were stored at temperature room and protected from the sun. 
  
Table 2: 0.5% Chloramphenicol eye drop formula 
Composition F0 (%) F1 (%) F2 (%) 
Chloramphenicol 0.50 0.50 0.50 
Boric acid 1.50 1.50 1.50 
Sodium tetraborate 0.30 0.30 0.30 
Thimerosal 0.00 0.01 0.001 
Sterile aqua pro injection (API) Ad 100 Ad 100 Ad 100 
 
For chloramphenicol eye drops formula, the chloramphenicol, boric 
acid, and sodium tetraborate were dissolved in a part of sterile API, 
then the thimerosal solution was added. Then remaining API was 
mixed with the mix ingredients and homogenized. Then the pH 
solution was measured. The solution was then sterilized using a 
bacterial filter.  
Evaluation of eye drops 
Evaluation of eye drops was carried out for 28 d, which included: 
visual observation, pH measurement, sterility and effectiveness test. 
Clarity observation 
The clarityinspection of eye drops was done by observing the 
clarity and color change of each container of eye drop 
preparations,with an observation time on days of 1,3,7,14,21 and 
28 during storage. 
pH 
pH of the prepared eye drops solution was measured by a pH 
meter. 
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Sterility test 
The eye drops bottle was aseptically opened and pipetted of 2 
ml. Each of 1 ml sample was inoculated into the FTM and TSB 
medium. Each test media were then incubated for 14 d at 30-35 
°C for FTM media, and at a temperature of 20-25 °C for TSB 
media. As a positive control both Bacillus subtilis and Candida 
albicans inoculated into the appropriate test media. FTM media 
were used for bacterial examination and used B. subtilis as the 
positive control. Meanwhile, TSB medium was used for 
examination of fungal contamination and used C. albicans as the 
positive control [28]. 
Efficacy test 
A total of 20 µl bacterial suspension was poured into a sterile petri 
dish containing MHA (45 °C), then the bacterial suspension was 
homogenized and allowed to solidify at room temperature. The 
media were then perforated using perforator aseptically. Each hole 
was filled with 50 µl of each formula solution and incubated for 18 h 
at 37 °C. The inhibitory diameters were measured using a caliper. 
Statistical analysis 
The effectivity data result was analyzed using Analysis method of 
Variance (ANOVA) for 3-factor factorial experiments. Where factor A 
was a group of bacteria, factor B was a group of formulas, and factor 
C was a group storage period. This test was intended to analyze if 
there were any a significant difference in the effect of the three types 
of treatment groups. Followed by Student Newman Keuls Test (S-N-
K Test) to determine the most stabile eye dropsformula from 
neomycin sulfate and chloramphenicol eye drops.  
RESULTS AND DISCUSSION  
Determination of thimerosal concentration 
Preservatives used in both eye drop preparation formulations 
served to prevent contamination and growth of pathogens during 
storage and use. This is an important agent to be formulated because 
while in use; microbial contamination may happen and lead to 
ocular infection or product degradation [17]. Therefore, protection 
of the product, an especially sterile product like an eye drops is 
essential to improve the product against the opportunistic 
contamination effects by using appropriate preservatives. 
Thimerosal is one of common preservative, use in eye drops 
preparation. In eye care, beside preservative has to kill microbes, 
but several preservatives can cause a little bit of toxicity to the 
ocular surface. Because of its organic-mercury (Hg) based 
compound in thimerosal, thimerosal was reported to be harmful. In 
contrast, the United States Centers for Disease Control and 
Prevention states that Thimerosal is safe and there is no relationship 
between thimerosal-containing vaccines and autism rates in 
children [18]. Therefore, considering the efficacy of thimerosal as 
preservatives in eye drops preparation, this study concerned with 
the determination of the low concentration of thimerosal that 
remain effective in preventing the contaminant growth. Based on the 
antibacterial test, the inhibition effects of thimerosal in different 
concentration against S. aureus, S. epidermidis and P. aeruginosa, 
were performed in the table 3-4. 
 
Table 3: Effect thimerosal inhibition as a preservative in 0.5% neomycin sulfate eye drops 
Formula Diameter of inhibition (mm) 
S. aureus S. epidermidis P. aeruginosa 
FA 34.6±0.000 25.8±0.000 25.7±0.060 
FA1 31.5±0.060 25.0±0.000 23.1±0.000 
FB 31.5±0.000 26.0±0.000 26.7±0.040 
FB1 25.9±0.040 21.3±0.035 25.4±0.000 
FC 30.0±0.020 24.5±0.050 22.6±0.000 
FC1 26.4±0.000 21.9±0.000 21.2±0.020 
FD 27.7±0.030 22.4±0.015 20.3±0.030 
FD1 24.3±0.030 19.2±0.000 14.8±0.000 
FE 24.0±0.000 14.7±0.000 19.6±0.020 
FE1 17.1±0.000 13.1±0.015 16.9±0.000 
Notes: Staphylococcus aureus (SA); Staphylococcus epidermidis (SE); Pseudomonas aeruginosa (PA); 0.5% neomycin sulfate+0.02%Thimerosal (FA); 
0.02%Thimerosal (FA1); 0.5% neomycin sulfate+0.015%Thimerosal (FB); 0.015%Thimerosal (FB1);0.5% neomycin sulfate+0.01%Thimerosal 
(FC);0.01%Thimerosal (FC1);0.5% neomycin sulfate+0.005%Thimerosal (FD);0.005%Thimerosal (FD1);0.5% neomycin sulfate+0.001%Thimerosal 
(FE); 0.001%Thimerosal (FE1); Each number of experiment replication= 3, Diameter of inhibition (mean±SD) 
 
Table 4: Effect thimerosal inhibition as a preservative in 0.5% chloramphenicol eye drops 
Formula Diameter of inhibition (mm) 
S. aureus S. epidermidis P. aeruginosa 
FA 39.4±0.010 32.4±0.000 31.0±0.080 
FA1 38.2±0.005 27.3±0.015 26.8±0.005 
FB 39.0±0.055 32.1±0.020 29.0±0.100 
FB1 36.8±0.065 26.6±0.045 21.0±0.005 
FC 38.3±0.005 31.5±0.005 30.2±0.090 
FC1 30.9±0.050 22.4±0.005 22.0±0.000 
FD 36.7±0.020 30.4±0.005 26.4±0.005 
FD1 30.6±0.020 17.5±0.005 21.3±0.005 
FE 34.8±0.045 29.3±0.005 26.9±0.020 
FE1 12.8±0.000 14.3±0.015 12.4±0.000 
Notes: Staphylococcus aureus (SA); Staphylococcus epidermidis (SE);Pseudomonas aeruginosa (PA); 0.5% chloramphenicol+0.02%Thimerosal 
(FA);0.02%Thimerosal (FA1); 0.5% chloramphenicol+0.015%Thimerosal (FB); 0.015%Thimerosal (FB1); 0.5% chloramphenicol+0.01%Thimerosal 
(FC); 0.01%Thimerosal (FC1); 0.5% chloramphenicol+0.005%Thimerosal (FD); 0.005%Thimerosal (FD1); 0.5% chloramphenicol+0.001% 
Thimerosal (FE); 0.001% Thimerosal (FE1); Each number of experiment replication= 3, Diameter of inhibition (mean±SD) 
 
Both the neomycin sulfate and chloramphenicol eye drop formula 
found that the higher the concentration of thimerosal used, the 
greater the diameter of inhibition. There was a significant difference 
in the inhibitory potency between formulas containing thimerosal, 
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compared to single thimerosal at related concentrations. The higher 
the concentration of thimerosal, the lower the rate of growth of the 
bacteria. But the smaller the concentration of preservatives used, 
the risk of side effects in eye drops can be reduced. Preservatives in 
eye drops are limited in concentration because they can cause side 
effects such as irritating the eyes and damaging the surface of the 
eyeball [29]. After determining the thimerosal concentration, the 
smallest effective concentration was 0.001%, thimerosal remains to 
provide antibacterial activity against all tested bacteria. 
Clarity observation 
Visual observation of eye drop preparations is needed to find out the 
presence of particles and supports the quality of eye drops. The 
assessment of eye drops clarity can be observed visually on white 
and black background in suitable lighting. The three formulas of 
each eye drop preparation showed that the eye drops were clear and 
there was no color change during the storage period. 
pH 
Measurement of pH in eye drops is very useful to prevent pain or eye 
discomfort after the use of eye drops. pH incompatibility in eyes may 
cause irritation and the drug bioavailability decreased because the 
tearing was increased [30]. Several studies mentioned that the pH 
range that can still be accepted by the eye is between pH 5.5-11.4, the 
range of 4–8 or the optimum pH for eye drops that equals tear fluid 
and is about 7.4 [30, 31]. Therefore, the pH of eye drops must be made 
to comply with the pH range that is suitable for the eye. The pH 
stability of the preparation is an important parameter in the 
evaluation of eye drop preparations, because pH changes not only 
result in unexpected side effects, pH also affects the action of the drug. 
pH changes in the both eye drops were measured for 28 d of storage 
using a pH meter. The pH of each eye drops solution changed over 
storage time. The pH changes of neomycin sulfate eye drops 
formulations were in the range of 6.45 to 6.60. It was found that 
there was a pH decreasing in F0 of neomycin sulfate eye drops 
formula, from 6.60 decreasing to 6.45 after 28 d of storage. Whereas 
F1 and F2 that are containing thimerosal, tend to be relatively stable, 
ranging from 6.60 to 6.60 after 28 d of storage. Unlike the 
chloramphenicol eye drops, changes in pH between F0 with F1 and 
F2 were not significantly different. Nevertheless, the highest pH 
decrease occurred at F0, from pH 7.19 down to 7.10. While the 
decrease in pH of F1 and F2 was 7.21 to 7.13 and 7.22 to 7.14 
respectively. The decreasing in pH among two eye drop solutions 
might because of the different buffering agent used in the formula, 
that has an important role in pH maintaining. The common buffer 
agents used in the formula of ophthalmic solutions are phosphate, 
citrate phosphate, citrate, acetate, bicarbonate, and borat [32]. 
Phosphate is the most-used buffer agent, as buffer agent used in the 
formula of neomycin sulfate in this study. Meanwhile, in 
cloramphenicol eye drops formula used boric acid.  
However, all pH formulas from both eye drops still comply the 
required pH of the eye drops. The pH values will describe the eye 
drop solution formula that are most compatible with eye physiology 
and are more stable during the storage time. The pH stability of each 
eye drop preparation formula containing 05% neomycin sulfate and 
0.5% chloramphenicol, can be observed in table 5 and fig. 1-2. 
Sterility test 
The basic characterization of eye drops as sterile preparations are totally 
free from all contaminants. The sterility of eye drop were required to be 
maintained during the period of use [33]. The sterility test of eye drop 
preparations includes fertility test, effectiveness test, and sterility test. In 
the fertility test, the used media showed growth of the bacteria and fungi 
used. This showed that the media can grow microorganisms so that they 
can be used for sterility tests for eye drops. The effectiveness test was 
useful to prove that the growth media was able to grow microorganisms 
after inoculating with the eye drop sample. The used media were FTM, 
which was implanted by Bacillus subtilis and TSB bacteria which were 
implanted with Candida albicans. 
The sterility of the products can be determined by observing the 
turbidity of the media after incubated for 14 at 30-35 °C for FTM 
media and at a temperature of 20-25 °C for TSB media [34]. All eye 
drops formulas were found as a sterile product during the storage 
time. This result suggested that the sterilization process of all 
formulas was done successfully because both F0 of the eye drops 
showed to be sterile after direct inoculation and there were not any 
microbial growth found in the media. Therefore, based on these 
sterility results, thimerosal role’s as the preservative agent in F1 and 
F2 formula, could not be explained. 
 
Table 5: The pH changes of 0.5% neomycin sulfate and 0.5% chloramphenicol eye drops over storage time 
Days pH of 0.5% neomycin sulfate  pH of 0.5% chloramphenicol  
F0 F1 F2 F0 F1 F2 
1 6.55±0.000 6.66±0.000 6.66±0.000 7.19±0.000 7.21±0.000 7.22±0.000 
3 6.55±0.000 6.66±0.000 6.66±0.000 7.18±0.000 7.20±0.000 7.22±0.000 
7 6.53±0.000 6.65±0.000 6.64±0.000 7.17±0.000 7.19±0.000 7.21±0.000 
14 6.51±0.000 6.63±0.000 6.62±0.000 7.16±0.000 7.17±0.000 7.20±0.000 
21 6.49±0.005 6.61±0.000 6.60±0.000 7.13±0.005 7.14±0.005 7.17±0.000 
28 6.45±0.005 6.60±0.005 6.60±0.000 7.10±0.000 7.13±0.005 7.14±0.005 
Notes: Each number of experiment replication= 3; pH changes ((mean±SD) 
 
 
Fig. 1: The pH changes of 0.5% neomycin sulfate eye drops over storage time, Notes: Each number of experiment replication= 3; pH 
changes (mean±SD) 
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Fig. 2: The pH changes of 0.5% chloramphenicol eye drops over storage time mean, notes: Each number of experiment replication= 3; pH 
changes (mean±SD) 
  
Efficacy test  
This study compared the antibacterial effectiveness of eye drops with 
thimerosal preservative at a concentration of 0.001% (F2) to the 
negative control (F0) and determine the effect of differences in 
thimerosal concentration compared with the positive control (F1). The 
efficacy test result during the storage time could be seen in table 6-7. 
All the formulas exhibited strong antibacterial against S. aureus, S. 
epidermidis, and P. aeruginosa. The most sensitive pathogen against all 
formulas was S. aureus. To determine the effect of thimerosal, the 
comparison antibacterial test between formula with the thimerosal 
addition (F1 and F2) and without thimerosal (F0). The efficacy test 
demonstrated that the existence of thimerosal in the formula, 
improving the antibacterial potency of the formula by observing the 
inhibitory diameter increasing. This combination produced a 
synergistic effect of the antibiotics and the thimerosal as a 
preservative agent against common eye pathogens. The formulas of 
chloramphenicol eye drops produced bigger diameter of inhibition 
than neomycin sulfate. These results were because of the different pH 
solution ranges. The pH of chloramphenicol eye drops were closely at 
neutral pH, while the neomycin sulfate were grouped into the weak 
acid solution. The different buffer component gave the main effect to 
pH values of the formulas. The pH values were reported gave an 
essential impact to thimerosal’s work. Thimerosal is stable in weak 
alkaline or neutral pH [35]; thus the effectivity of thimerosal in 
chloramphenicol eye drops was better than in neomycin sulfate. 
  
Table 6: Antibacterial efficacy of 0.5% neomycin sulfate eye drop 
Formula Bacteria  Diameter of inhibition (mm)  %decrease 
1 3 7 14 21 28 
F0 SA 22.2±0.000 22.2±0.000 21.2±0.000 20.5±0.005 18.7±0.000 17.8±0.000 19.8 
 SE 23.0±0.000 22.8±0.005 20.4±0.000 20.1±0.000 20.1±0.000 19.2±0.002 16.5 
 PA 21.2±0.000 20.9±0.004 20.0±0.000 19.0±0.005 18.1±0.000 14.0±0.000 33.9 
F1 SA 23.3±0.002 22.9±0.000 22.3±0.005 21.2±0.005 20.0±0.000 19.7±0.000 15.4 
 SE 20.3±0.001 19.9±0.000 19.3±0.005 19.0±0.000 18.6±0.005 18.1±0.000 10.8 
 PA 23.5±0.000 23.3±0.005 22.7±0.004 21.7±0.000 20.1±0.000 19.3±0.000 17.8 
F2 SA 22.3±0.005 22.3±0.000 21.4±0.005 21.1±0.000 18.9±0.000 18.0±0.000 19.2 
 SE 22.1±0.000 22.0±0.004 20.2±0.000 20.0±0.000 19.0±0.000 18.8±0.005 14.9 
 PA 22.3±0.000 22.2±0.000 20.8±0.000 19.6±0.005 19.0±0.000 18.6±0.000 16.5 
Notes: Each number of experiment replication= 3 (triplo); Diameter of inhibition (mean±SD) 
 
During the storage time, the antibacterial efficacy of all formulas 
tends to be decreased. Among all formulas, F0 showed the 
significant inhibitory diameter decrease. This data informed that the 
thimerosal had an important role in inhibiting the bacterial growth. 
Based on statistical analysis for the interaction between the formula 
factor of neomicyn sulfate eye drops on the inhibitory diameter, 
resulted that Fcount (770.875) was greater than Ftable (3.168), thus 
H0was rejected. It described that there was a difference in the effect 
of the formula on the inhibitory diameter. In other words, each 
formula (F0, F1, and F2) showed different inhibition diameters. F0 
preparations experienced a significant decrease in effectiveness 
compared to F1 and F2. While the difference in the decrease in the 
effectiveness of F1 and F2 was not significant, therefore, considering 
the thimerosal side effect in high-level doses, the insignificant 
difference in the effectiveness of F1 and F2 could be the logic reason 
to use 0.001%thimerosal preservatives in the eye drop formulas 
than 0.01%thimerosal. Whereas, based on the influence of bacterial 
type factors on inhibitory diameter, it was found that Fcount 
(127,392) was greater than Ftable (3,168) so that H0 was rejected. 
This showed that there were differences in the effect of bacterial 
types on inhibitory diameter. In other words, each formula of 0.5% 
neomycin sulfate eye drops provides different effectiveness for each 
test bacteria. Likewise, for storage period factor, Fcount (773,474) 
was greater than Ftable (2,386) so H0
The same analysis result was obtained from ANOVA statistycal 
calculation for 0.5% chloramphenicol eye drops. There were 
influences between the formula factor, bacterial type and storage time 
on the inhibitory diameter of each chloramphenicol eye drops formula. 
Based on the Newman-Keuls test, it was known that there were 
differences in the effect of dosage formulas, storage times and test 
bacteria. Interaction of dosage formulas with storage time, storage 
time with test bacteria, and dosage formulas with significant test 
bacteria in all chloramphenicol eye drops. These data indicated that 
the use of thimerosal preservatives proved to be needed in the eye 
drops formulation to reduce the diameter of the inhibitory decreasing.
was rejected. This showed that 
the difference in storage effect on inhibitory diameter. By the 
increasing of storage time, the diameter of the inhibition formed was 
smaller, meaning the effectiveness of the preparation decreases. 
Based on Student Newman Keuls (SNK test), there were significant 
results for each test bacteria, formula, and storage period of 
inhibitory diameter and conclusion that S. aureus had the highest 
average inhibitory diameter, meaning that the bacteria were the 
most influential against 0.5% neomycin sulfate eye drops. 
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Table 7: Antibacterial efficacy of 0.5% chloramphenicoleye drop 
Formula Bacteria  Diameter of inhibition (mm)  % decrease 
1 3 7 14 21 28 
F0 SA 36.7±0.000 34.8±0.000 32.4±0.000 31.7±0.005 29.6±0.000 28.7±0.004 21.7 
 SE 31.9±0.000 30.7±0.002 29.4±0.002 27.7±0.000 25.6±0.000 23.6±0.000 26.0 
 PA 26.7±0.000 25.8±0.000 24.4±0.000 22.6±0.005 20.6±0.000 17.8±0.000 33.3 
F1 SA 38.4±0.005 37.7±0.000 36.6±0.000 35.5±0.000 34.8±0.000 32.9±0.000 14.3 
 SE 33.5±0.000 32.8±0.000 31.8±0.000 30.5±0.000 28.9±0.000 26.4±0.000 21.1 
 PA 29.8±0.000 28.5±0.005 26.6±0.005 24.5±0.000 22.9±0.000 21.9±0.005 26.5 
F2 SA 37.4±0.004 36.6±0.000 35.4±0.000 34.0±0.000 33.7±0.000 31.8±0.000 14.9 
 SE 32.6±0.000 31.9±0.004 30.8±0.000 28.9±0.005 27.6±0.000 25.9±0.000 20.5 
 PA 27.4±0.000 26.6±0.000 24.4±0.000 23.4±0.000 20.7±0.000 18.8±0.000 31.3 
Notes: Each number of experiment replication= 3 (triplo); Diameter of inhibition (mean±SD) 
 
CONCLUSION 
In conclusion, the investigated effect of thimerosal as a preservative 
agent was very essential in supporting the quality and efficacy of eye 
drop products containing neomycin sulfate and chloramphenicol.  
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